Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News bluebird bio Inc BLUE

Healthcare Biotechnology
bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its lentiviral vector (LVV) gene addition platform. Its lead gene therapy programs for sickle cell disease, B-thalassemia, and cerebral adrenoleukodystrophy and is advancing research to apply new... see more

Recent & Breaking News (NDAQ:BLUE)

Global Blood Therapeutics (GBT) doubles on IPO, raising $120m on sickle cell research

Canadian Press August 12, 2015

bluebird bio Reports Second Quarter 2015 Financial Results and Recent Operational Progress

Business Wire August 6, 2015

bluebird bio Announces Participation at the 2015 Wedbush PacGrow Healthcare Conference

Business Wire August 5, 2015

bluebird bio Announces Pricing of Public Offering of Common Stock

Business Wire June 23, 2015

bluebird bio Announces Proposed Public Offering of Common Stock

Business Wire June 23, 2015

Kite Pharma and bluebird bio Announce Strategic Collaboration to Advance Second Generation TCR Cell Therapy Products to Treat HPV-Associated Cancers

GlobeNewswire June 22, 2015

Philip Gregory, D. Phil., Joins bluebird bio as Chief Scientific Officer

Business Wire June 15, 2015

bluebird bio Reports New Beta-thalassemia Major and Severe Sickle Cell Disease Data from HGB-205 Study at EHA

Business Wire June 13, 2015

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE

PR Newswire June 10, 2015

bluebird bio Completes NIH RAC Review of HGB-208 Pediatric Study Protocol

Business Wire June 9, 2015

Celgene and bluebird bio to Develop Anti-BCMA Product Candidates; bluebird bio Regains Rights to CAR T Programs Outside of BCMA

Business Wire June 3, 2015

bluebird bio and Five Prime Therapeutics Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy

GlobeNewswire May 26, 2015

bluebird bio Announces Participation at the Jefferies 2015 Global Healthcare Conference

Business Wire May 22, 2015

bluebird bio to Present LentiGlobin Clinical Data at 20th Congress of European Hematology Association

Business Wire May 21, 2015

bluebird bio Announces Global Regulatory Strategy for LentiGlobin BB305 in Beta-Thalassemia Major

Business Wire May 19, 2015

bluebird bio Reports First Quarter 2015 Financial Results and Business Updates

Business Wire May 6, 2015

bluebird bio Announces Participation at Two Upcoming Health Care Conferences

Business Wire April 30, 2015

bluebird bio to Present at Alliance for Regenerative Medicine's 3rd Annual Regen Med Investor Day

Business Wire March 18, 2015

bluebird bio Reports Fourth Quarter and Full Year 2014 Financial Results and Recent Operational Progress

Business Wire February 25, 2015

General Maritime Corporation And Navig8 Crude Tankers Inc. To Combine To Create The Largest Owner Of Modern Eco VLCCs

PR Newswire February 25, 2015